Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores.

Sashidhara KV, Kumar M, Modukuri RK, Srivastava RK, Soni A, Srivastava K, Singh SV, Saxena JK, Gauniyal HM, Puri SK.

Bioorg Med Chem. 2012 May 1;20(9):2971-81. doi: 10.1016/j.bmc.2012.03.011. Epub 2012 Mar 10.

PMID:
22464685
2.

Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.

Sashidhara KV, Avula SR, Palnati GR, Singh SV, Srivastava K, Puri SK, Saxena JK.

Bioorg Med Chem Lett. 2012 Sep 1;22(17):5455-9. doi: 10.1016/j.bmcl.2012.07.028. Epub 2012 Jul 14.

PMID:
22850213
3.

Synthesis of chiral chloroquine and its analogues as antimalarial agents.

Sinha M, Dola VR, Soni A, Agarwal P, Srivastava K, Haq W, Puri SK, Katti SB.

Bioorg Med Chem. 2014 Nov 1;22(21):5950-60. doi: 10.1016/j.bmc.2014.09.009. Epub 2014 Sep 16.

PMID:
25284252
4.

Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.

Pandey S, Agarwal P, Srivastava K, Rajakumar S, Puri SK, Verma P, Saxena JK, Sharma A, Lal J, Chauhan PM.

Eur J Med Chem. 2013 Aug;66:69-81. doi: 10.1016/j.ejmech.2013.05.023. Epub 2013 May 28.

PMID:
23792317
5.

Search for new pharmacophores for antimalarial activity. Part III: synthesis and bioevaluation of new 6-thioureido-4-anilinoquinazolines.

Mishra A, Srivastava K, Tripathi R, Puri SK, Batra S.

Eur J Med Chem. 2009 Nov;44(11):4404-12. doi: 10.1016/j.ejmech.2009.06.001. Epub 2009 Jun 12.

PMID:
19586687
6.

Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.

Kondaparla S, Soni A, Manhas A, Srivastava K, Puri SK, Katti SB.

Bioorg Chem. 2017 Feb;70:74-85. doi: 10.1016/j.bioorg.2016.11.010. Epub 2016 Nov 23.

PMID:
27908538
7.

Novel oxazine skeletons as potential antiplasmodial active ingredients: Synthesis, in vitro and in vivo biology of some oxazine entities produced via cyclization of novel chalcone intermediates.

Tiwari V, Meshram J, Ali P, Sheikh J, Tripathi U.

J Enzyme Inhib Med Chem. 2011 Aug;26(4):569-78. doi: 10.3109/14756366.2010.539566. Epub 2010 Dec 20.

PMID:
21171899
8.

Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity.

Sunduru N, Sharma M, Srivastava K, Rajakumar S, Puri SK, Saxena JK, Chauhan PM.

Bioorg Med Chem. 2009 Sep 1;17(17):6451-62. doi: 10.1016/j.bmc.2009.05.075. Epub 2009 Jun 6.

PMID:
19665899
9.

Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.

Biot C, Glorian G, Maciejewski LA, Brocard JS.

J Med Chem. 1997 Nov 7;40(23):3715-8.

PMID:
9371235
10.

The novel oxygenated chalcone, 2,4-dimethoxy-4'-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo.

Chen M, Brøgger Christensen S, Zhai L, Rasmussen MH, Theander TG, Frøkjaer S, Steffansen B, Davidsen J, Kharazmi A.

J Infect Dis. 1997 Nov;176(5):1327-33.

PMID:
9359735
11.

Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.

Rojas Ruiz FA, García-Sánchez RN, Estupiñan SV, Gómez-Barrio A, Torres Amado DF, Pérez-Solórzano BM, Nogal-Ruiz JJ, Martínez-Fernández AR, Kouznetsov VV.

Bioorg Med Chem. 2011 Aug 1;19(15):4562-73. doi: 10.1016/j.bmc.2011.06.025. Epub 2011 Jun 15.

PMID:
21723734
12.

Antimalarial activity of ferrocenyl chalcones.

Wu X, Wilairat P, Go ML.

Bioorg Med Chem Lett. 2002 Sep 2;12(17):2299-302.

PMID:
12161120
13.

Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity.

Musonda CC, Whitlock GA, Witty MJ, Brun R, Kaiser M.

Bioorg Med Chem Lett. 2009 Jan 15;19(2):481-4. doi: 10.1016/j.bmcl.2008.11.047. Epub 2008 Nov 18.

PMID:
19054674
14.

Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.

Sinha M, Dola VR, Agarwal P, Srivastava K, Haq W, Puri SK, Katti SB.

Bioorg Med Chem. 2014 Jul 15;22(14):3573-86. doi: 10.1016/j.bmc.2014.05.024. Epub 2014 May 20.

PMID:
24906512
15.

4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.

Kumar A, Srivastava K, Kumar SR, Siddiqi MI, Puri SK, Sexana JK, Chauhan PM.

Eur J Med Chem. 2011 Feb;46(2):676-90. doi: 10.1016/j.ejmech.2010.12.003. Epub 2010 Dec 9.

PMID:
21194812
16.

In vitro antimalarial activity of chalcones and their derivatives.

Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN, Davidson E, Kurzban G, Miller RE, Nuzum EO, et al.

J Med Chem. 1995 Dec 22;38(26):5031-7.

PMID:
8544179
17.

Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.

Rafatro H, Ramanitrahasimbola D, Rasoanaivo P, Ratsimamanga-Urverg S, Rakoto-Ratsimamanga A, Frappier F.

Biochem Pharmacol. 2000 May 1;59(9):1053-61.

PMID:
10704934
18.

Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides.

Smit FJ, N'da DD.

Bioorg Med Chem. 2014 Feb 1;22(3):1128-38. doi: 10.1016/j.bmc.2013.12.032. Epub 2013 Dec 22.

PMID:
24411478
19.

In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria.

Rasoanaivo P, Ratsimamanga-Urverg S, Milijaona R, Rafatro H, Rakoto-Ratsimamanga A, Galeffi C, Nicoletti M.

Planta Med. 1994 Feb;60(1):13-6.

PMID:
8134408
20.

Supplemental Content

Support Center